Sunburn
Conditions
Keywords
Melatonin, Sunburn, Erythema, Sunlight, Ultraviolet rays
Brief summary
The aim of this study is to investigate the sun protective effect of melatonin, when used as a cream applied before sun exposure. Sun exposure induces erythema as indication of an inflammatory reaction in the skin. It is proven that the amount of free radicals in the skin are increased by UV exposure. Furthermore, it is known that melatonin is a potent antioxidant. It is hypothesized that melatonin can be protective against the UV induced release of free radicals by acting as a radical scavenger and thereby protect against UV-induced cellular damage.
Detailed description
This study investigates the sun protective effect of melatonin when used as a creme applied before sun exposure. The study is a randomized, placebo-controlled, double-blinded study conducted on healthy volunteers. The volunteers will have 5 squares of 8 cm\*8 cm on their backs, which each will be randomized to receive one of following: melatonin cream 0,5%; melatonin cream 2,5%; melatonin cream 12,5%; placebo cream (vehicle) and no treatment. After randomization and received treatment the volunteers will be exposed to strong midday sun (UV-index of approximately 9) for 40 minutes. The outcomes parameters (degree of erythema and pain sensation) are measured at baseline and 1,4,8 and 24 hours post exposure.
Interventions
DRUGMelatonin
Sponsors
Herlev Hospital
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Healthy volunteers of both sexes. * Skin type 1-3 according to Fitzpatrick skin type scale. * No sun exposure on skin area tested in the study 4 weeks prior to the study.
Exclusion criteria
* Active skin disease * Participant that do not react to the given sun exposure with a change in a-value \>5 are excluded from the data. * Pregnancy * Previous malignant or pre malignant skin disease.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction of erythema assessed by digital image analysis (Image J) after treatment with melatonin/placebo before sun exposure. | Primary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure | The alpha value measured in a color space converted image will represent the degree of erythema |
Secondary
| Measure | Time frame |
|---|---|
| Testing for primary hyperalgesia in the sun exposed area with Pin-Prick monofilaments. Testing for primary hyperalgesia in the sun-exposed area with Pin-Prick monofilaments. | The secondary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure. |
Other
| Measure | Time frame |
|---|---|
| Visual inspection of erythema using Frosch-Klingman scale. | This secondary outcome is assessed at: baseline and 1,4,8 and 24 hours post exposure |
Countries
Denmark
Outcome results
None listed